» Articles » PMID: 40017589

Efficacy of Anthelmintics Against Canine Hookworm Infections in the Bono East Region of Ghana

Overview
Journal J Parasitol Res
Publisher Wiley
Specialty Parasitology
Date 2025 Feb 28
PMID 40017589
Authors
Affiliations
Soon will be listed here.
Abstract

Hookworm infections present a major health risk to dogs, especially in areas characterized by warmer climates and poor sanitation. This cross-sectional study was undertaken to determine the prevalence of hookworm infections and the efficacy of anthelmintic treatments in dogs from the Bono East Region of Ghana. Four hundred and ninety-one (491) canine stool samples were examined using the McMaster technique to ascertain the prevalence of hookworms. Using in vivo and in vitro techniques, the efficacy of three anthelmintics (albendazole, pyrantel, and niclosamide) was assessed in an experimental control trial involving dogs naturally infected with hookworms. The effects of the drugs on hematological and biochemical parameters were measured within a 14-day period to assess changes over time. The study found a total prevalence of 54.2% (266), with significantly higher infection rates in puppies (69.8%, 97), hunting dogs (64.1%, 91), and rural dogs (84.2%, 160). Logistic regression identified age, purpose, and settlement type as risk factors for infection. Of the three treatments, niclosamide was the most efficacious, reducing egg counts by 95%, while albendazole was the least efficacious (-69%). In vitro tests confirmed the superior performance of niclosamide, with the lowest IC value of 29.19 g/mL. Hookworm-infected dogs exhibited anemia, eosinophilia, hypoalbuminemia, and hypoproteinemia. There was significant improvement in the hematobiochemical parameters after treatment, particularly in niclosamide-treated dogs. Veterinarians can consider niclosamide, especially in resource-limited settings, due to its affordability. The findings emphasize the importance of regular monitoring and treatment of hookworm infections to improve the overall health and well-being of dogs in the region. Herein, we report for the first time on reduced efficacy of albendazole and pyrantel against dog-related hookworms in Ghana.

References
1.
Paredes A, Litterio N, Dib A, Allemandi D, Lanusse C, Bruni S . A nanocrystal-based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs. J Pharm Pharmacol. 2017; 70(1):51-58. DOI: 10.1111/jphp.12834. View

2.
Johnson S, Cunningham M, Dippenaar I, Sharara F, Wool E, Agesa K . Public health utility of cause of death data: applying empirical algorithms to improve data quality. BMC Med Inform Decis Mak. 2021; 21(1):175. PMC: 8170729. DOI: 10.1186/s12911-021-01501-1. View

3.
Dale A, Xu G, Kopp S, Jones M, Kotze A, Abdullah S . Pyrantel resistance in canine hookworms in Queensland, Australia. Vet Parasitol Reg Stud Reports. 2024; 48:100985. DOI: 10.1016/j.vprsr.2024.100985. View

4.
Umbrello G, Pinzani R, Bandera A, Formenti F, Zavarise G, Arghittu M . Hookworm infection in infants: a case report and review of literature. Ital J Pediatr. 2021; 47(1):26. PMC: 7871578. DOI: 10.1186/s13052-021-00981-1. View

5.
Merino-Tejedor A, Nejsum P, Mkupasi E, Johansen M, Olsen A . Molecular identification of zoonotic hookworm species in dog faeces from Tanzania. J Helminthol. 2018; 93(3):313-318. DOI: 10.1017/S0022149X18000263. View